Cardiac Allograft Vasculopathy
📧 Sign up to get email alerts when something new happens for Cardiac Allograft Vasculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-06Clinical Trial Update: Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
A clinical trial investigating the association between microvascular disease by PET and graft injury via donor-derived cell-free DNA has bee…
-
CLINICAL_TRIALS withdrawal · 2019-03-14Clinical Trial Update: A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV) [Phase 3]
Phase 3 trial evaluating Thymoglobulin® to prevent cardiac allograft vasculopathy in heart transplant recipients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-25Clinical Trial Update: Noninvasive Predictors of Transplant Vasculopathy
The clinical trial 'Noninvasive Predictors of Transplant Vasculopathy' (NCT01424917) investigating cardiac allograft vasculopathy has been w…
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients [NA]
A clinical trial evaluating strategies to prevent cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Noninvasive Evaluation of Cardiac Allograft Vasculopathy
A clinical trial evaluating noninvasive evaluation of cardiac allograft vasculopathy was withdrawn by the sponsor, University of Minnesota.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-06-20Clinical Trial Update: Coronary Artery Study in Pediatric Heart Transplantation
A pediatric heart transplant trial focusing on coronary artery disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-19Clinical Trial Update: Severe CAV MRI in Heart Transplant Recipient
A clinical trial evaluating MRI for severe cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.